Department of Nephrology, Peking University Third Hospital, Beijing, China.
Department of Cardiology, Cardiovascular Hospital Affiliated to Xiamen University, Xiamen, China.
Ren Fail. 2021 Dec;43(1):1601-1608. doi: 10.1080/0886022X.2021.2011316.
Peritoneal dialysis (PD) was introduced in China more than 60 years ago and has grown continuously since then. Now China leads the first of the world in number of patients on PD. In this manuscript a brief review of the history of peritoneal dialysis in China is presented; this includes a description of pioneers and their important contributions, discussion of peritoneal dialysate, the technique of the use of Tenckhoff catheter, the use of continuous ambulatory peritoneal dialysis (CAPD) and dialysis registration. Current ongoing PD research activities among Chinese PD academicians are also discussed. Finally, we present four areas of future focus: 1) the promotion of PD in rural areas where PD use is still very limited due to the lack of PD awareness and education; 2) PD quality management and continuous quality improvement (CQI) program particularly focusing on PD adequacy and patient rehabilitation; 3) development and enforcement of national standards on PD management; 4) multi-center studies to compare the benefits of PD and hemodialysis (HD) that should include survival, rehabilitation and cost-effectiveness.
腹膜透析(PD)在中国已经有 60 多年的历史,自那时起一直在不断发展。现在中国的 PD 患者数量居世界首位。本文简要回顾了中国 PD 的历史,包括对先驱者及其重要贡献的描述,对腹膜透析液的讨论,Tenckhoff 导管使用技术,持续非卧床腹膜透析(CAPD)和透析登记的讨论。还讨论了中国 PD 学者目前正在进行的 PD 研究活动。最后,我们提出了未来四个重点关注领域:1)在农村地区推广 PD,由于缺乏 PD 意识和教育,农村地区 PD 的使用仍然非常有限;2)PD 质量管理和持续质量改进(CQI)计划,特别是关注 PD 充分性和患者康复;3)制定和执行 PD 管理的国家标准;4)多中心研究比较 PD 和血液透析(HD)的益处,其中应包括生存率,康复和成本效益。